Children's Cardiomyopathy Foundation Research Grant Program
CCF's grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting of preliminary data to help secure long-term funding by the National Institutes of Health and other major granting institutions.
Principal investigator must hold an M.D., Ph.D. or equivalent degree and reside in the United States or Canada. The investigator must have a faculty appointment at an accredited U.S. or Canadian medical institution and have the ability to conduct independent research with publications in established peer-reviewed medical and scientific journals.
Funding is available in the range of US$25,000 to US$50,000 for one year of total direct costs. Following the completion of the proposed study, a second year of funding may be requested by application. Upon receipt of a signed CCF letter of agreement and IRB or IACUC approval, CCF will disburse funds in installments during the grant period.
CCF requires a letter of intent in advance of the grant application. The 2013 deadline for Letters of Intent is Friday, June 14 by 5:00 p.m. Eastern Standard Time. Only investigators who have submitted a Letter of Intent and have been invited to submit a formal grant application will be considered for CCF funding.
The submission deadline for full grant applications is Friday, September 6, 2013 by 5:00 p.m. Eastern Standard Time with final award decisions to be made in January 2014.
Grant award decisions are made through a careful and detailed peer-review selection process led by CCF's Medical Advisors and approved by CCF's Board of Directors. A study's scientific excellence and relevance to primary forms of pediatric cardiomyopathy is key to being selected for research funding. Details about the grant review process can be obtained by downloading CCF's Grant Requirements & Guidelines document.